SCHEMBL4877937

SCHEMBL4877937

CN(C)CCOc1ccccc1/C=C/C(=O)c1ccccc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 6/20 0.63
LMNA P02545 3/20 0.63
MAPT P10636 3/20 0.63
NPC1 O15118 2/20 0.63
RAB9A P51151 1/20 0.63
ACHE P22303 5/20 0.63
SMN1; SMN2 Q16637 2/20 0.57
ATM Q13315 1/20 0.57
KEAP1 Q14145 1/20 0.54
NFE2L2 Q16236 1/20 0.54
HRH1 P35367 1/20 0.53
KDM4E B2RXH2 4/20 0.52
ALDH1A1 P00352 4/20 0.52
MAOB P27338 2/20 0.52
CYP1A2 P05177 2/20 0.51
CYP2D6 P10635 2/20 0.51
CYP1A1 P04798 1/20 0.51
CYP1B1 Q16678 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4877945 1.00 BCHE (0.63) BCHELMNAMAPTNPC1RAB9A
Citric Acid SCHEMBL25191073 0.89 LMNA (0.61) BCHELMNAMAPTNPC1RAB9A
Citric Acid SCHEMBL25265210 0.89 LMNA (0.61) BCHELMNAMAPTNPC1RAB9A
SCHEMBL4853315 0.88 BCHE (0.56) BCHELMNAMAPTNPC1RAB9A
SCHEMBL4853758 0.88 BCHE (0.56) BCHELMNAMAPTNPC1RAB9A
SCHEMBL4854809 0.86 NR1H4 (0.50) BCHELMNAMAPTNPC1RAB9A
SCHEMBL4847357 0.86 NR1H4 (0.50) BCHELMNAMAPTNPC1RAB9A
SCHEMBL8330993 0.83 MAPT (0.80) BCHELMNAMAPTNPC1RAB9A
SCHEMBL8330997 0.83 MAPT (0.80) BCHELMNAMAPTNPC1RAB9A
SCHEMBL29772318 0.83 MAPT (0.66) BCHELMNAMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed